Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases

Serum alpha-fetoprotein (AFP) levels elevated in benign liver diseases (BLD) represent a challenge in hepatocellular carcinoma (HCC) diagnosis. The present study aimed to develop a simple method to identify HCC in AFP-elevated liver diseases based on combining serum fluorescence and general clinical...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Wang, Ting, Zhang, Kun-He, Hu, Piao-Ping, Wan, Qin-Si, Han, Fang-Li, Zhou, Jian-Ming, Huang, De-Qiang, Lv, Nong-Hua
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2017
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716689/
https://ncbi.nlm.nih.gov/pubmed/29228649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22050
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires